HCA Healthcare (NYSE:HCA – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Royal Bank Of Canada in a research note issued to investors on Monday,Benzinga reports. They currently have a $435.00 price target on the stock. Royal Bank Of Canada’s price target points to a potential upside of 12.46% from the stock’s previous close.
A number of other brokerages have also commented on HCA. Stephens decreased their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Wells Fargo & Company set a $369.00 price target on HCA Healthcare in a report on Monday, July 20th. Oppenheimer cut their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a research report on Thursday, June 4th. Finally, Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $480.86.
View Our Latest Analysis on HCA
HCA Healthcare Trading Up 1.2%
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the company posted $6.84 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. On average, equities analysts forecast that HCA Healthcare will post 29.19 EPS for the current year.
Institutional Investors Weigh In On HCA Healthcare
Hedge funds have recently modified their holdings of the stock. Palisade Asset Management LLC purchased a new position in HCA Healthcare in the third quarter valued at approximately $26,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at $31,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare in the 1st quarter worth about $33,000. JPL Wealth Management LLC purchased a new stake in HCA Healthcare during the third quarter valued at about $33,000. Finally, MCF Advisors LLC increased its stake in shares of HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after purchasing an additional 49 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
HCA Healthcare News Summary
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Quarterly results exceeded expectations: HCA reported second-quarter revenue of approximately $20.23 billion, up 8.7% year over year and above estimates, while adjusted earnings of $7.59 per share narrowly topped consensus. Net income reached about $1.7 billion. HCA Healthcare Q2 CY2026 sales top estimates
- Positive Sentiment: Florida Medicaid supported profitability: A Florida Medicaid program helped boost second-quarter profit, providing a favorable contribution to results. HCA Healthcare 2Q Profit Boosted by Florida Medicaid Program
- Positive Sentiment: Analysts remain broadly constructive: Oppenheimer lowered its price target to $485 but maintained an “outperform” rating, while KeyCorp reduced its target to $435 and kept an “overweight” rating. Both targets imply additional upside from the recent trading level. Analyst price-target updates
- Neutral Sentiment: Dividend announced: HCA declared a quarterly dividend of $0.78 per share, payable September 30 to shareholders of record September 16. The annualized yield is approximately 0.8%.
- Negative Sentiment: Full-year outlook was reduced: Management cut its 2026 profit outlook, tempering the impact of the quarterly beat and signaling pressure on expected earnings growth. HCA posts $1.7B net income and cuts 2026 profit outlook
- Negative Sentiment: Compliance concerns persist: A monitor identified potential noncompliance at Mission Health for the third consecutive year, creating regulatory and reputational risk. Mission monitor reports potential noncompliance
- Negative Sentiment: Coverage headwinds remain: ACA-related volume declines have reportedly shifted nearly one-for-one to uninsured patients, potentially pressuring payer mix and margins. HCA Healthcare ACA coverage disruptions
- Negative Sentiment: Price targets were broadly lowered: Robert W. Baird cut its target to $393 with a “neutral” rating, and Barclays reduced its target to $387 with an “equal weight” rating, reflecting more limited near-term upside. Analyst price-target reductions
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Innovative ETF Strategies That Are Paying Off This Summer
- Forget Tesla: These 2 Earnings Reports Reveal Where the Auto Market Is Heading
- This Tiny AI Supplier Could Be More Important Than the Chipmakers
- Meta Earnings Put AI Spending and Ad Growth Back in Focus
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
